Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2861-2870 of 2921 for cancer

Edit search filters
  1. A Study to Create a Database of Clinical Information and a Repository of Specimens for Genetic, Molecular and Microbiological Research to Better Understand Hereditary Cancer and Help Develop New Therapies and Preventive Strategies

    Scottsdale/Phoenix, AZ

  2. Immunogenicity And Safety Of Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) In Patients With Hematologic Malignancies And Associated Precursors

    Rochester, MN

  3. Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202)

    Rochester, MN

  4. Study To Learn More About The Safety And Effectiveness Of The Drug VITRAKVI During Routine Use In Patients With TRK Fusion Cancer Which Is Locally Advanced Or Spread From The Place Where It Started To Other Places In The Body

    Jacksonville, FL, Rochester, MN

  5. A Comparison Study To Cross-validate The Linear Analogue Self-Assessment (LASA), Patient-Reported Outcomes Measurement Information System (PROMIS), And Patient-reported Outcomes Version Of The Common Terminology Criteria For Adverse Events (PRO-CTCAE) In Assessing Cancer Patient Well-being

    Rochester, MN

  6. ATHN 9: Severe Von Willebrand Disease Natural History Study

    Rochester, MN

  7. A Registry for the Collection of Biological and Clinical Data for Studies of Immune System Related Blood Disorders

    Rochester, MN

  8. Towards Precise and Rapid Diagnosis of Heparin-Induced Thrombocytopenia: a Prospective, Multicentre Cohort Study (“TORADI-HIT”)

    Jacksonville, FL

  9. A Study to Evaluate Immune Regulation at the Point Where Maternal Genes and Fetus Genes Meet in the Human Placenta

    Rochester, MN

  10. A Study To Measure The Circulating Tumor Cells In The Blood Of The Portal And Hepatic Veins Of The Liver During The Transplant Surgery Of Patients With Liver Cancer

    Rochester, MN

.

Mayo Clinic Footer